Year :
2021
| Month :
September
| Volume :
15
| Issue :
9
| Page :
SR01 - SR03
Full Version
Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Infection: A Case Series
Published: September 1, 2021 | DOI: https://doi.org/10.7860/JCDR/2021/49495.15332
Aneesha Mathew, Akshay K Nair, Harish Kumar, Renoy Phillip, Rini Susan Varghese
1. Student, Department of Pharmacy, K.L.E College of Pharmacy, Bangalore, Karnataka, India.
2. Student, Department of Pharmacy, K.L.E College of Pharmacy, Bangalore, Karnataka, India.
3. Paediatric Intensivist, Department of Paediatrics, Aster CMI Hospital, Bangalore, Karnataka, India.
4. Clinical Pharmacist, Department of Pharmacy Practice, Aster CMI Hospital, Bangalore, Karnataka, India.
5. Assistant Professor, Department of Pharmacy Practice, K.L.E College of Pharmacy, Bangalore, Karnataka, India.
Correspondence Address :
Dr. Akshay K Nair,
Kuzhippillil House, Kottiyoor P.O, Panniyamala, Iritty (taluk), Kannur, Kerala, India.
E-mail: akshayknair5000@gmail.com
Abstract
Multisystem Inflammatory Syndrome (MIS) is a newer, rarer and dangerous childhood disease that require early attention and is associated with Coronavirus Disease-2019 (COVID-19) infection. This article reports four clinically ill children of age 6-15 years admitted to Aster CMI Hospital, Bengaluru, Karnataka, India, during October and November 2020. The diagnosis was based on elevated laboratory values (D-Dimer, C-Reactive Protein (CRP), and Ferritin) and positive COVID-19 antibody test. No infectious aetiologies were identified. All patients presented at Emergency Room (ER) with hypotensive shock and were treated with inotropic support, Intravenous Immunoglobulin (IVIg), and steroids. Children responded well to treatment and were discharged within a period of 8-11 days. Clinical characteristics are necessary for understanding more about newly identified paediatric illness.
Keywords
Coronavirus disease-2019, Intravenous immunoglobulin, Multisystem inflammatory
syndrome in children, Severe acute respiratory syndrome coronavirus-2
10.7860/JCDR/2021/49495.15332
Date of Submission: Mar 19, 2021
Date of Peer Review: Jun 25, 2021
Date of Acceptance: Jul 26, 2021
Date of Publishing: Sep 01, 2021
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. No
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Mar 20, 2021
• Manual Googling: Jul 26, 2021
• iThenticate Software: Aug 19, 2021 (6%)
ETYMOLOGY: Author Origin
|